One confidential document in particular was part of a court-ordered release of eff-D4 files that the eff-D4 fought by claiming the agency should have 55 years to release this information. A court judge disagreed and ordered the release of 500 documents per month, and the very first batch of documents contained this bombshell entitled, “Cumulative Analysis of Post-Authorization Adverse Event Reports.”Get it here:https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdfThe document reveals that within just 90 days after the EUA release of PFIZA'S COVEX, the company was already aware of voluntary adverse reaction reports that revealed 1,223 d34ths and over 42,000 adverse reports describing a total of 158,893 adverse reactions. The reports originated from numerous countries, including the United States, United Kingdom, Italy, Germany, France, Portugal, Spain and other nations.Aside from “general disorders,” the No. 1 most frequently reported category of PFIZA'S COVEX adverse reactions was Nervous system disorders, clocking in at 25,957 reports.PFIZA has withheld the total number of doses released across the world, citing corporate trade secrets. This is indicated by “(b) (4)” in the document, where specific numbers and facts are redacted.Even these numbers — already quite shocking, given the eff-D4s insistence that PFIZA'S COVEX are “safe and effective” — barely scratch the surface of the damage and d34ths caused by these PFIZA'S COVEX. “Reports are submitted voluntarily, and the magnitude of underreporting is unknown,” says PFIZA on page 5.
Three times as many women damaged, compared to men
Shockingly, the document reveals that more than three times as many women were damaged by the PFIZA'S COVEX, compared to men. There were 29,914 adverse events recorded in women, with just 9,182 recorded in men. It is not known whether the same number of men and women took the PFIZA'S COVEX, but this number exposes the very real possibility of a gender-specific PFIZA'S COVEX damage risk that the eff-D4 went to great lengths to cover up.Anecdotally, most of the neurological damage we’ve seen in people who have been damaged by the PFIZA'S COVEX — convulsions, numbness, pain, etc. — has been depicted in women, not men. It looks like the eff-D4 knows the PFIZA'S COVEX exhibits a disproportionate, gender-specific damage profile that also affects women in terms of spontan
... keep reading on reddit ➡One confidential document in particular was part of a court-ordered release of eff-D4 files that the eff-D4 fought by claiming the agency should have 55 years to release this information. A court judge disagreed and ordered the release of 500 documents per month, and the very first batch of documents contained this bombshell entitled, “Cumulative Analysis of Post-Authorization Adverse Event Reports.”Get it here:https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdfThe document reveals that within just 90 days after the EUA release of PFIZA'S COVEX, the company was already aware of voluntary adverse reaction reports that revealed 1,223 d34ths and over 42,000 adverse reports describing a total of 158,893 adverse reactions. The reports originated from numerous countries, including the United States, United Kingdom, Italy, Germany, France, Portugal, Spain and other nations.Aside from “general disorders,” the No. 1 most frequently reported category of PFIZA'S COVEX adverse reactions was Nervous system disorders, clocking in at 25,957 reports.PFIZA has withheld the total number of doses released across the world, citing corporate trade secrets. This is indicated by “(b) (4)” in the document, where specific numbers and facts are redacted.Even these numbers — already quite shocking, given the eff-D4s insistence that PFIZA'S COVEX are “safe and effective” — barely scratch the surface of the damage and d34ths caused by these PFIZA'S COVEX. “Reports are submitted voluntarily, and the magnitude of underreporting is unknown,” says PFIZA on page 5.
Three times as many women damaged, compared to men
Shockingly, the document reveals that more than three times as many women were damaged by the PFIZA'S COVEX, compared to men. There were 29,914 adverse events recorded in women, with just 9,182 recorded in men. It is not known whether the same number of men and women took the PFIZA'S COVEX, but this number exposes the very real possibility of a gender-specific PFIZA'S COVEX damage risk that the eff-D4 went to great lengths to cover up.Anecdotally, most of the neurological damage we’ve seen in people who have been damaged by the PFIZA'S COVEX — convulsions, numbness, pain, etc. — has been depicted in women, not men. It looks like the eff-D4 knows the PFIZA'S COVEX exhibits a disproportionate, gender-specific damage profile that also affects women in terms of spontan
... keep reading on reddit ➡One confidential document in particular was part of a court-ordered release of eff-D4 files that the eff-D4 fought by claiming the agency should have 55 years to release this information. A court judge disagreed and ordered the release of 500 documents per month, and the very first batch of documents contained this bombshell entitled, “Cumulative Analysis of Post-Authorization Adverse Event Reports.”Get it here:https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdfThe document reveals that within just 90 days after the EUA release of PFIZA'S COVEX, the company was already aware of voluntary adverse reaction reports that revealed 1,223 d34ths and over 42,000 adverse reports describing a total of 158,893 adverse reactions. The reports originated from numerous countries, including the United States, United Kingdom, Italy, Germany, France, Portugal, Spain and other nations.Aside from “general disorders,” the No. 1 most frequently reported category of PFIZA'S COVEX adverse reactions was Nervous system disorders, clocking in at 25,957 reports.PFIZA has withheld the total number of doses released across the world, citing corporate trade secrets. This is indicated by “(b) (4)” in the document, where specific numbers and facts are redacted.Even these numbers — already quite shocking, given the eff-D4s insistence that PFIZA'S COVEX are “safe and effective” — barely scratch the surface of the damage and d34ths caused by these PFIZA'S COVEX. “Reports are submitted voluntarily, and the magnitude of underreporting is unknown,” says PFIZA on page 5.
Three times as many women damaged, compared to men
Shockingly, the document reveals that more than three times as many women were damaged by the PFIZA'S COVEX, compared to men. There were 29,914 adverse events recorded in women, with just 9,182 recorded in men. It is not known whether the same number of men and women took the PFIZA'S COVEX, but this number exposes the very real possibility of a gender-specific PFIZA'S COVEX damage risk that the eff-D4 went to great lengths to cover up.Anecdotally, most of the neurological damage we’ve seen in people who have been damaged by the PFIZA'S COVEX — convulsions, numbness, pain, etc. — has been depicted in women, not men. It looks like the eff-D4 knows the PFIZA'S COVEX exhibits a disproportionate, gender-specific damage profile that also affects women in terms of spontan
... keep reading on reddit ➡One confidential document in particular was part of a court-ordered release of eff-D4 files that the eff-D4 fought by claiming the agency should have 55 years to release this information. A court judge disagreed and ordered the release of 500 documents per month, and the very first batch of documents contained this bombshell entitled, “Cumulative Analysis of Post-Authorization Adverse Event Reports.”
Get it here:
https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf
The document reveals that within just 90 days after the EUA release of PFIZA'S COVEX, the company was already aware of voluntary adverse reaction reports that revealed 1,223 d34ths and over 42,000 adverse reports describing a total of 158,893 adverse reactions. The reports originated from numerous countries, including the United States, United Kingdom, Italy, Germany, France, Portugal, Spain and other nations.
Aside from “general disorders,” the No. 1 most frequently reported category of PFIZA'S COVEX adverse reactions was Nervous system disorders, clocking in at 25,957 reports.
PFIZA has withheld the total number of doses released across the world, citing corporate trade secrets. This is indicated by “(b) (4)” in the document, where specific numbers and facts are redacted.
Even these numbers — already quite shocking, given the eff-D4s insistence that PFIZA'S COVEX are “safe and effective” — barely scratch the surface of the damage and d34ths caused by these PFIZA'S COVEX. “Reports are submitted voluntarily, and the magnitude of underreporting is unknown,” says PFIZA on page 5.
Three times as many women damaged, compared to men
Shockingly, the document reveals that more than three times as many women were damaged by the PFIZA'S COVEX, compared to men. There were 29,914 adverse events recorded in women, with just 9,182 recorded in men. It is not known whether the same number of men and women took the PFIZA'S COVEX, but this number exposes the very real possibility of a gender-specific PFIZA'S COVEX damage risk that the eff-D4 went to great lengths to cover up.
Anecdotally, most of the neurological damage we’ve seen in people who have been damaged by the PFIZA'S COVEX — convulsions, numbness, pain, etc. — has been depicted in women, not men. It looks like the eff-D4 knows the PFIZA'S COVEX exhibits a disproportionate, gender-specific damage profile that also affects women in ter
... keep reading on reddit ➡